AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows


A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns.


By APOORVA MANDAVILLI | NYTimes Health | Disclosure

Comments